SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma’s arm acquires 11.86% stake in PJSC Biosintez

13 Mar 2019 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma (Netherlands) BV has increased its shareholding in PJSC Biosintez, Russia, by way of purchase of 33958 shares equivalent to 11.86% of PJSC Biosintez under Mandatory Tender Offer.

Post the aforesaid purchase, the total holding of Sun Pharma (Netherlands) BV was increased from 85.10% to 96.96% in PJSC Biosintez.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1874.40 27.10 (1.47%)
11-May-2026 13:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.40
Dr. Reddys Lab 1293.30
Cipla 1314.70
Zydus Lifesciences 945.90
Lupin 2266.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×